What medications can relax esophageal contractions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications for Relaxing Esophageal Contractions

Baclofen is the most effective medication for relaxing esophageal contractions and is recommended as first-line pharmacologic therapy for regurgitation or belch-predominant GERD symptoms. 1

First-Line Options

GABA-B Agonists

  • Baclofen:
    • Primary mechanism: Inhibits transient lower esophageal sphincter relaxations
    • Dosing: Typically started at 5-10mg three times daily, can be titrated up as needed
    • Best for: Regurgitation and belch-predominant symptoms 1
    • Limitations: Central nervous system and GI side effects (drowsiness, dizziness, nausea) 1

Second-Line Options

Calcium Channel Blockers

  • Diltiazem, Nifedipine:
    • Mechanism: Relax smooth muscle by blocking calcium influx
    • Effectiveness: May help in diffuse esophageal spasm and hypercontractile esophagus ("nutcracker esophagus") 2, 3
    • Limitations: Clinical response often disappointing despite manometric improvement 2
    • Side effects: May worsen GERD symptoms by relaxing the lower esophageal sphincter 4

Nitrates

  • Isosorbide dinitrate, Nitroglycerin:
    • Mechanism: Smooth muscle relaxation via nitric oxide
    • Effectiveness: Limited evidence in controlled trials 5
    • Limitations: Short duration of action, tolerance development, headaches

Anticholinergics

  • Hyoscyamine, Glycopyrrolate:
    • Mechanism: Block muscarinic receptors, reducing smooth muscle contractions
    • Effectiveness: Limited evidence in controlled trials for esophageal motility disorders 5
    • Limitations: Can worsen GERD by relaxing the lower esophageal sphincter 4

Patient Selection Algorithm

  1. Identify the predominant symptom pattern:

    • Regurgitation/belching → Baclofen (first-line) 1
    • Esophageal spasm/chest pain → Consider calcium channel blockers 2, 3
  2. Consider comorbidities:

    • Coexistent GERD: Avoid medications that may worsen reflux (calcium channel blockers, nitrates, anticholinergics) 4
    • Gastroparesis: Consider adding a prokinetic agent 1
  3. Evaluate for contraindications:

    • Baclofen: Seizure disorders, severe renal impairment
    • Calcium channel blockers: Hypotension, heart failure
    • Nitrates: Hypotension, use of phosphodiesterase inhibitors

Monitoring and Follow-up

  • Assess response after 4-8 weeks of therapy
  • If inadequate response to baclofen, consider:
    • Increasing dose if tolerated
    • Switching to calcium channel blockers if spasm is the predominant feature
    • Adding neuromodulators for hypersensitivity (low-dose antidepressants) 1

Important Caveats

  • Medications that relax esophageal contractions often have limited clinical efficacy despite physiologic effects 2
  • Most evidence comes from small studies with conflicting results 5
  • Prokinetic agents like metoclopramide are not recommended as monotherapy for GERD due to limited efficacy and significant side effects (including a black box warning) 1
  • Medications that relax the lower esophageal sphincter (calcium channel blockers, nitrates) may potentially worsen GERD symptoms 4
  • Consider objective testing (manometry, pH monitoring) to confirm diagnosis before escalating therapy 1

Special Populations

  • Pediatric patients: Evidence for prokinetics is insufficient to support routine use in children with GERD 1
  • Achalasia patients: Pharmacologic therapy is generally inferior to procedural interventions (pneumatic dilation, POEM, surgical myotomy) 1

For patients with persistent symptoms despite pharmacologic therapy, consider referral for endoscopic or surgical management options based on the specific motility disorder.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Esophageal pharmacology and treatment of primary motility disorders.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 1999

Research

Efficacy of diltiazem in the treatment of diffuse oesophageal spasm.

Alimentary pharmacology & therapeutics, 1990

Research

Medication-induced oesophageal disorders.

Expert opinion on drug safety, 2003

Research

Current medical therapy for esophageal motility disorders.

The American journal of medicine, 1992

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.